LONDON, March 23 /PRNewswire/ -- The "2008 European Tissue Sealants & Topical Hemostats Product Differentiation Innovation Award" is conferred on Nycomed in recognition of its revolutionary product - TachoSil. The innovative surgical patch, TachoSil is poised to be the future of the European tissue sealants and topical hemostats markets. At present, Nycomed, with TachoSil, is the sole company in the market with a ready-to-use dual action patch. TachoSil is unique: it does not fit into any of the standard market segments and constitutes a separate category on its own. "This pioneering product has both haemostatic and sealing properties and can be used to stop bleeding as well seal tissue," explains Frost & Sullivan Research Analyst Divya Belle. "TachoSil combines the bioactive mechanism of action of human coagulation factors fibrinogen and thrombin with a collagen patch for mechanical support."
No comments:
Post a Comment